Delivery Order SPE2DB24D3013-SPE2DB25FFQKW
- Not listed
- The Defense Logistics Agency awarded a $5,681.22 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Dexamethasone 0.5 mg/5 ml elixir in a 237 ml quantity, with an ultimate completion date of August 21, 2025. This competitively awarded contract utilizes firm fixed-price pricing and does not include a set-aside designation. The product will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a $1,837.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexamethasone 0.5 mg/5 mL elixir (237 mL), with an ultimate completion date of August 11, 2025. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,619.29 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Dexamethasone 10 mg/mL vials. This competitively awarded, firm fixed-price delivery order is set to conclude on August 13, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $4,131.41 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Dexamethasone 0.5 mg/5 mL elixir in a 237 mL quantity, with ultimate completion scheduled for July 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $4,113.35 for 100 tablets of Dexamethasone 4 mg, with an ultimate completion date of August 19, 2025. This competitive award, issued on August 18, 2025, employs firm fixed-price pricing and involves no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Dexamethasone 20 mg/5 ml vials in 5 ml quantities, with a ceiling value of $1,046.46. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. This delivery...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp., a subsidiary of Amerisourcebergen Corporation, to provide 237 mL bottles of 0.5 mg/5 mL dexamethasone elixir. The $1,231.40 award has a completion date of February 5, 2024. Amerisourcebergen Drug Corp. is a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. This...
- The Defense Logistics Agency awarded a $4,707.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexamethasone 20 mg/5 mL vials on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from the vendor's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.52 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 20 mg/5 ml vials on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The contract involves the delivery of a corticosteroid medication commonly utilized across military and federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,188.80 firm fixed-price delivery order is for the supply of 4566401459 dexamethasone 10 mg/ml vials, with a completion date of November 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQKWDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,910.94 for Dexamethasone 0.5 mg/5 ml elixir (237 ml) on September 10, 2025, with completion scheduled for September 11, 2025. The contract utilized firm fixed-price pricing and was not designated as a set-aside award, indicating it was competitively awarded. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems through its IDC with the DLA Medical Supply Chain. The company maintains an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for dexamethasone, a corticosteroid commonly used in military and federal medical treatment protocols, represents one of numerous competitively awarded transactions under the company's prime vendor agreement for supplying essential medications to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/10/25 |